Carl Sandén

5PUBLICATIONS
25CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Innate immunityHaematological tumoursSpeciation and extinction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 25, 2025
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.

Henrik Lilljebjörn, Pablo Peña-Martínez, Hanna Thorsson

|Oct 03, 2025
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.

Carl Sandén, Niklas Landberg, Pablo Peña-Martínez

|Nov 16, 2022
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.

Sofia von Palffy, Hanna Thorsson, Pablo Peña-Martínez

|Feb 07, 2020
Clonal competition within complex evolutionary hierarchies shapes AML over time.

Carl Sandén, Henrik Lilljebjörn, Christina Orsmark Pietras

Pageof 1